Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity
Project: IberusExperience
Updated at: 01-01-2025
Project: IberusExperience
Updated at: 01-01-2025
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 01-11-2024
Project: IberusExperience
Updated at: 28-04-2024
Project: IberusExperience
Updated at: 28-04-2024
Project: IberusExperience
Updated at: 28-04-2024